Applied Therapeutics, Inc. — Director's Dealing 2021

Feb 17, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2020-12-31

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-02	Common Stock	G	200000	$0.00	Disposed	354285	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1750000	Indirect
Common Stock	1492094	Indirect
Common Stock	709780	Indirect
Common Stock	290280	Indirect
Common Stock	88397	Indirect

Footnotes

F1: Through a grantor retained annuity trust.

F2: Through a family trust controlled by the reporting person's spouse.

F3: Through the reporting person's spouse.

F4: Through a family trust controlled by the reporting person.

F5: Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.